Premium
The owners of Sterling Biotech--Generic drugmaker Zydus Lifesciences Ltd and private equity Temasek-backed Perfect Day Inc—plan to restructure some of the businesses of their jointly-held venture, including its active pharmaceutical ingredient (API) and gelatine businesses, a person aware of the matter told VCCircle. Zydus Lifesciences had signed an agreement with Temasek-backed food technology company ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
